FDA Biosimilar Approval Foreshadows IP Litigation Issues

By Sean Sheridan and Archan Ruparel
September 15, 2021, 4:38 PM EDT

In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time.[1]...

Already a subscriber? Click here to view full article